Form 4 for CRL Charles River Laboratories
Accepted 2026-06-02 16:27:29 ET · period of report 2026-05-29 · accession 0001100682-26-000089 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-02 16:27 | 2026-05-29 | CRL | Creamer Victoria L | EVP, CHRO | A - Grant | $180.71 | +5,135 | 30.9K | +20% | +$927.9K | |
| M | 2026-06-02 16:27 | 2026-05-30+ | CRL | Creamer Victoria L | EVP, CHRO | F - Tax | $180.71 | -810 | 30.1K | -3% | -$146.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-29 | A | A | 5,135 | $180.71 | 30,861 | D | — | — | (F1) Unvested restricted stock units annually ratably vest on: May 29, 2027; May 29, 2028; May 29, 2029; May 29, 2030. |
| 2 | Common | Common Stock | 2026-05-30 | F | D | 616 | $180.71 | 30,245 | D | — | — | |
| 3 | Common | Common Stock | 2026-05-31 | F | D | 194 | $180.71 | 30,051 | D | — | — |